MERCURNA
Mercurna is a Nijmegen-based biotech startup determined to deliver a first-of-its-kind precision medicine for chronic kidney disease.
MERCURNA
Industry:
Biopharma Biotechnology
Founded:
2013-01-01
Address:
Oss, Noord-Brabant, The Netherlands
Country:
The Netherlands
Website Url:
http://www.mercurna.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
71.43 K EUR
Technology used in webpage:
Euro Microsoft Exchange Online Office 365 Mail Google Maps ReCAPTCHA Microsoft Azure DNS ReCAPTCHA V2
Similar Organizations
Cellestia
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
Enterin
Philadelphia-based biotechnology company .
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Mercurna
Official Site Inspections
http://www.mercurna.com
- Host name: 77.111.243.61
- IP address: 77.111.243.61
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
More informations about "Mercurna"
Homepage (new) - Mercurna
Mercurna is a Dutch biotechnology start-up that develops messenger RNA (mRNA)-based medicines. To that end, we are continuously perfecting our platform technology which …See details»
About us - Mercurna
Mercurna was founded in 2017 with the goal to develop truly life-changing medicines. We consider medicines life-changing if they deliver a cure where previously unavailable, or when …See details»
Mercurna - Crunchbase Company Profile & Funding
Mercurna is a developer of life-changing mRNA medicines. They also develop modular nanomedicines that can be adapted to a multitude of diseases with ease. They built a …See details»
Mercurna - LinkedIn
Mercurna is a Netherlands-based biotech startup developing messenger RNA (mRNA) based medicines.See details»
Careers - Mercurna
Our organization allows you to take the lead in your project and affords ample opportunities to develop your career within our rapidly growing company. Join us, in our pursuit of the next life …See details»
Mercurna Company Profile - Office Locations, Competitors ... - Craft
Mercurna is a biotech company delivering messenger RNA (mRNA) based medicines. It offers a platform technology that combines cell-targeting ligands with a proprietary lipid-based delivery …See details»
Mercurna - Products, Competitors, Financials, Employees, …
Mercurna is a biotechnology company focused on developing messenger RNA (mRNA)-based medicines for the healthcare sector. Use the CB Insights Platform to explore Mercurna's full …See details»
Mercurna - Crunchbase
Mercurna is a biotechnology start-up that develops messenger RNA-based medicines.See details»
Mercurna - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 · Mercurna is a biotechnology start-up that develops messenger RNA-based medicines.See details»
Mercurna - Company Profile - Tracxn
Mar 23, 2024 · Mercurna is involved in the development of mRNA based therapeutics. The company offers its propriety platform to deliver engineered mRNA for treatment for diseases of …See details»
Our mission (new) - Mercurna
Our lead formulation consists of an unique cocktail of mRNAs, encoding for therapeutic proteins, that attacks the disease at its root and brings back the homeostasis in the kidney.See details»
Mercurna - Funding, Financials, Valuation & Investors - Crunchbase
Mercurna is a biotechnology start-up that develops messenger RNA-based medicines.See details»
Mercurna - Overview, News & Similar companies | ZoomInfo.com
Mercurna is a Netherlands-based biotech startup developing messenger RNA (mRNA) based medicines. To that end we are continuously perfecting our platform technology which …See details»
Venture Challenge alumnus Mercurna reaches important scientific …
Oct 8, 2021 · Mercurna has reached its scientific and IP milestones of the RedMedtech Discovery Fund II (RMDFII) by providing exciting data (in vitro and in vivo) on mCura1, Mercurna’s lead …See details»
Mercurna has reached its scientific and IP milestones of the …
We are pleased to share that Mercurna has reached its scientific and IP milestones of the RedMedtech Discovery Fund II (RMDFII) by providing exciting data (in vitro and in vivo) on …See details»
Welcome to a new team member - Mercurna
Oct 1, 2024 · We are confident that her capabilities will contribute to Mercurna’s mission: “To deliver life-changing medicines for patients with inflammatory diseases, based on the software …See details»
Mercurna - VentureRadar
Website: http://www.mercurna.com. Develops mRNA synthesis and therapies using a unique targeting peptide, forming nanoparticles that enable specific kidney drug delivery and reduce …See details»
Mercurna - Contacts, Employees, Board Members, Advisors
Mercurna is a biotechnology start-up that develops messenger RNA-based medicines.See details»
Mercurna - Lifesciences @ Work
At Mercurna, we are developing a first-in-class therapy to charter this market, based on the identification of a unique kidney-targeting peptide.See details»
Our future (new) - Mercurna
Learn more about where we want to go in the upcoming years. Finalizing our lead. In the upcoming months we will still work hard on the final aspects of our lead formulation and make …See details»